Grifols SA (GRFS)
6.27
-0.12
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
6.27
0.00 (0.00%)
After-Hours: 20:00
Grifols Total Liabilities (Quarterly): 14.89B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.89B |
| September 30, 2023 | 14.29B |
| June 30, 2023 | 14.35B |
| December 31, 2022 | 14.02B |
| June 30, 2022 | 13.18B |
| June 30, 2021 | 11.04B |
| March 31, 2021 | 10.48B |
| December 31, 2020 | 10.52B |
| September 30, 2020 | 10.03B |
| June 30, 2020 | 9.624B |
| March 31, 2020 | 9.584B |
| December 31, 2019 | 9.742B |
| September 30, 2019 | 9.568B |
| June 30, 2019 | 9.594B |
| March 31, 2019 | 9.557B |
| December 31, 2018 | 8.900B |
| September 30, 2018 | 8.869B |
| June 30, 2018 | 8.628B |
| March 31, 2018 | 8.834B |
| December 31, 2017 | 8.741B |
| September 30, 2017 | 8.744B |
| June 30, 2017 | 8.616B |
| March 31, 2017 | 8.433B |
| December 31, 2016 | 6.768B |
| Date | Value |
|---|---|
| September 30, 2016 | 6.771B |
| June 30, 2016 | 6.816B |
| March 31, 2016 | 6.734B |
| December 31, 2015 | 6.888B |
| September 30, 2015 | 6.724B |
| June 30, 2015 | 6.754B |
| March 31, 2015 | 6.757B |
| December 31, 2014 | 7.037B |
| September 30, 2014 | 7.059B |
| June 30, 2014 | 6.874B |
| March 31, 2014 | 6.833B |
| December 31, 2013 | 5.156B |
| September 30, 2013 | 5.049B |
| June 30, 2013 | 5.085B |
| March 31, 2013 | 4.903B |
| December 31, 2012 | 4.955B |
| September 30, 2012 | 5.143B |
| June 30, 2012 | 5.069B |
| March 31, 2012 | 5.137B |
| December 31, 2011 | 5.149B |
| September 30, 2011 | 5.281B |
| June 30, 2011 | 5.546B |
| December 31, 2010 | 1.571B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.568B
Minimum
Sep 2019
14.89B
Maximum
Dec 2023
11.49B
Average
10.50B
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 42.80M |
| Adaptimmune Therapeutics PLC | 243.10M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.70B |
| Shareholders Equity (Quarterly) | 6.441B |
| Debt to Equity Ratio | 1.546 |
| Current Ratio | 2.786 |
| Net Debt Paydown Yield | -2.78% |